LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA – Apellis Pharmaceuticals, Inc. Transaction History
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA portfolio value:
$8.85M
portfolio value
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -33.59% | -65.54K shares | 26K | $68.3 | 129.57K |
| Q2 2022 | share | Decrease | -11.81% | -26.12K shares | -2.41M | $45.22 | 195.12K |
| Q1 2022 | share | Decrease | -47.78% | -202.42K shares | -8.78M | $50.81 | 221.25K |
| Q4 2021 | share | Increase | +104.93% | 216.93K shares | 13.21M | $47.95 | 423.67K |
| Q3 2021 | share | Decrease | -47.66% | -188.28K shares | -18.15M | $32.96 | 206.74K |
| Q2 2021 | share | Increase | +4.12% | 15.63K shares | 8.68M | $63.2 | 395.03K |
| Q1 2021 | share | Increase | 0.00% | 379.39K shares | 16.28M | $42.91 | 379.39K |